MALAT1 Promotes Tumorigenesis and Increases Cellular Sensitivity to Herceptin in HER2-positive Breast Cancer

CONCLUSION: In short, MALAT1 might be a potential biomarker and therapeutic target for HER2-positive breast cancer therapy.PMID:34148540 | DOI:10.2174/1568009621666210618164300

Source: Current Cancer Drug Targets - June 21, 2021 Category: Cancer & Oncology Authors: Chuansheng Yang Hongbo Zhu Yeru Tan Renjie Zhu Xiaoping Wu Yuehua Li Cunchuan Wang Source Type: research